# Johnson & Johnson (JNJ) — Q3-2017 Earnings Results

**Report date:** 2017-10-17 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2017

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Reaction Not Available

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.90 | N/A | +4.19% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their product pipeline and market strategies. They are focused on maintaining growth despite market challenges.

**Key quotes:**

> Management highlighted strong performance in key segments.

> They emphasized ongoing commitment to innovation and market expansion.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

This earnings report shows that Johnson & Johnson exceeded expectations on EPS, indicating solid profitability. However, the lack of revenue data and guidance leaves some uncertainty about future performance. Investors will be looking for more clarity in upcoming reports to gauge the company's trajectory.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2017_